Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia

M. Ghanem (Paris, France), M. Homps-Legrand (Paris, France), L. Morer (Paris, France), T. Goletto (Paris, France), J. Frija (Paris, France), C. Bancal (Paris, France), M. Hurtado-Nedelec (Paris, France), M. Jaillet (Paris, France), A. Mailleux (Paris, France), C. Neukirch (Paris, France), R. Borie (Paris, France), C. Taille (Paris, France), B. Crestani (Paris, France)

Source: Virtual Congress 2021 – COVID - 19 biomarkers
Session: COVID - 19 biomarkers
Session type: E-poster
Number: 642

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Ghanem (Paris, France), M. Homps-Legrand (Paris, France), L. Morer (Paris, France), T. Goletto (Paris, France), J. Frija (Paris, France), C. Bancal (Paris, France), M. Hurtado-Nedelec (Paris, France), M. Jaillet (Paris, France), A. Mailleux (Paris, France), C. Neukirch (Paris, France), R. Borie (Paris, France), C. Taille (Paris, France), B. Crestani (Paris, France). Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia. 642

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical features and outcome of patients with acute exacerbation of interstitial pneumonia associated with collagen vascular disease
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010

Treatment and prognosis of lung cancer associated with interstitial pneumonia
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010


Elevated blood eosinophils on admission for a severe exacerbation of COPD is not a predictor for survival
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017

Prevalence and prognosis of unclassifiable interstitial lung disease
Source: Eur Respir J 2014; 43: 1529-1530
Year: 2014


Prevalence and prognosis of unclassifiable interstitial lung disease
Source: Eur Respir J 2013; 42: 750-757
Year: 2013



Blood eosinophils in COPD and the future risk of pneumonia
Source: Eur Respir J, 52 (1) 1800981; 10.1183/13993003.00981-2018
Year: 2018



Clinical characteristics and prognosis of fibrotic nonspecific interstitial pneumonia
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


Lymphoid interstitial pneumonia: clinical features, associations and prognosis
Source: Eur Respir J 2006; 28: 364-369
Year: 2006



Increased TNFα production in whole blood is associated with disease severity in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 497s
Year: 2002

Associations of COPD severity and severity of exacerbation with sputum microbiologic profile and long-term survival
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


D-dimer elevation is associated with severity of community-acquired pneumonia according to CURB-65 and PSI
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006


Procalcitonin and clinical pulmonary infection score as predictors of stroke associated pneumonia.
Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers
Year: 2018

Admission lactate predicts poor prognosis independently of the CRB/CURB-65 scores in community-acquired pneumonia.
Source: International Congress 2017 – Update on community acquired pneumonia
Year: 2017



Histology is not a prognostic indicator in patients with interstitial pneumonias associated with systemic sclerosis
Source: Eur Respir J 2001; 18: Suppl. 33, 526s
Year: 2001

Associations between comorbidities and survival in patients with interstitial lung diseases
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021


Prognostic determinants in IPF patients with the histological features of usual interstitial pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 526s
Year: 2001

Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD
Source: Eur Respir J, 50 (5) 1701162; 10.1183/13993003.01162-2017
Year: 2017



A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2014 – IPF and surroundings
Year: 2014

Neutrophil extracellular traps levels are associated to severity and complications in community-acquired pneumonia
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020


Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies
Source: International Congress 2016 – Connective tissue disorders
Year: 2016